DYN logo

Dyne Therapeutics (DYN) Shareholders equity

annual shareholders equity:

$629.84M+$538.55M(+589.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual stockholders equity is $629.84 million, with the most recent change of +$538.55 million (+589.92%) on December 31, 2024.
  • During the last 3 years, DYN annual shareholders equity has risen by +$261.64 million (+71.06%).
  • DYN annual shareholders equity is now at all-time high.

Performance

DYN Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

quarterly shareholders equity:

$668.97M+$39.13M(+6.21%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly stockholders equity is $668.97 million, with the most recent change of +$39.13 million (+6.21%) on March 31, 2025.
  • Over the past year, DYN quarterly shareholders equity has increased by +$190.92 million (+39.94%).
  • DYN quarterly shareholders equity is now -13.70% below its all-time high of $775.19 million, reached on June 30, 2024.

Performance

DYN quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

DYN Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+589.9%+39.9%
3 y3 years+71.1%+98.8%
5 y5 years+4387.3%-

DYN Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+589.9%-13.7%+632.8%
5 y5-yearat high+4387.3%-13.7%+632.8%
alltimeall timeat high>+9999.0%-13.7%+4666.1%

DYN Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$668.97M(+6.2%)
Dec 2024
$629.84M(+589.9%)
$629.84M(-10.7%)
Sep 2024
-
$705.54M(-9.0%)
Jun 2024
-
$775.19M(+62.2%)
Mar 2024
-
$478.06M(+423.7%)
Dec 2023
$91.29M(-63.8%)
$91.29M(-40.0%)
Sep 2023
-
$152.04M(-26.5%)
Jun 2023
-
$206.88M(-14.5%)
Mar 2023
-
$241.94M(-4.1%)
Dec 2022
$252.36M
$252.36M(+1.0%)
Sep 2022
-
$249.74M(-13.0%)
DateAnnualQuarterly
Jun 2022
-
$287.06M(-14.7%)
Mar 2022
-
$336.46M(-8.6%)
Dec 2021
$368.20M(+7.5%)
$368.20M(-11.1%)
Sep 2021
-
$414.12M(-8.5%)
Jun 2021
-
$452.60M(-5.4%)
Mar 2021
-
$478.26M(+39.7%)
Dec 2020
$342.37M(+2339.2%)
$342.37M(-6.7%)
Sep 2020
-
$366.85M(+176.9%)
Jun 2020
-
$132.48M(+843.9%)
Dec 2019
$14.04M(-387.7%)
$14.04M
Dec 2018
-$4.88M
-

FAQ

  • What is Dyne Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Dyne Therapeutics?
  • What is Dyne Therapeutics annual shareholders equity year-on-year change?
  • What is Dyne Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly shareholders equity year-on-year change?

What is Dyne Therapeutics annual stockholders equity?

The current annual shareholders equity of DYN is $629.84M

What is the all time high annual shareholders equity for Dyne Therapeutics?

Dyne Therapeutics all-time high annual stockholders equity is $629.84M

What is Dyne Therapeutics annual shareholders equity year-on-year change?

Over the past year, DYN annual stockholders equity has changed by +$538.55M (+589.92%)

What is Dyne Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of DYN is $668.97M

What is the all time high quarterly shareholders equity for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly stockholders equity is $775.19M

What is Dyne Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, DYN quarterly stockholders equity has changed by +$190.92M (+39.94%)
On this page